Key result
Mavacamten improves quantitative measures of obstruction and symptom relief in obstructive hypertrophic cardiomyopathy, allowing patients to defer invasive management.
Why the study?
Mavacamten recently demonstrated quantitative and symptomatic improvement in obstructive hypertrophic cardiomyopathy, prompting a review of its pharmacology, clinical trial data, practical clinical guidance, and emerging therapies.
This review highlights mavacamten as an effective therapy for obstructive hypertrophic cardiomyopathy that improves obstruction and symptoms, potentially deferring the need for invasive management.
May enable deferral of septal reduction in oHCM; leaves open long-term durability and use beyond obstructive phenotypes.
Hypertrophic cardiomyopathy (HCM) is a condition with abnormal hypertrophy of the left ventricle in the absence of common causes. The most common form involves the basal septum and can lead to obstruction of the left ventricular outflow tract. Patients can experience exertional symptoms such as chest pain, dyspnea and syncope. Traditional treatment has included beta blockers and nondihydropyridine calcium channel blockers with second-line therapy being disopyramide. Recently, mavacamten, a cardiac myosin inhibitor, has demonstrated improvement in quantitative measures of obstruction and symptom relief to such a degree that patients were able to defer invasive management of the disease. This review focuses on the pharmacology of mavacamten, its clinical trial data and guidance on how to incorporate this drug into clinical practice. Furthermore, it discusses emerging therapies currently being investigated for HCM.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2023) conducted a review in Obstructive Hypertrophic Cardiomyopathy. Mavacamten was evaluated. Mavacamten improves quantitative measures of obstruction and symptom relief in obstructive hypertrophic cardiomyopathy, allowing patients to defer invasive management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: